Ascertainment of minimal clinically important differences in the diabetes distress scale–17: a secondary analysis of a randomized clinical trial
Banks J, Amspoker AB, Vaughan EM, et al.
JAMA Netw Open. 2023;6(11):e2342950.
Leggi
Breaking news
Type 2 diabetes and colorectal cancer risk
Lawler T, Walts ZL, Steinwandel M, et al.
JAMA Netw Open. 2023;6(11):e2343333.
Leggi
Global trends in the burden of chronic kidney disease attributable to type 2 diabetes: an age‐period‐cohort analysis
Liu W, Zhang D, Wang R, et al.
Diabetes Obes Metab. Pub. online 7 Nov 2023.
Leggi
Glomerular and tubular effects of dapagliflozin, eplerenone and their combination in patients with chronic kidney disease: A post‐hoc analysis of the ROTATE‐3 study
Lieverse TTGF, Puchades MJ, Mulder UDJ, et al.
Diabetes Obes Metab. Pub. online 5 Nov 2023.
Leggi
A randomised controlled trial assessing the impact of CGM with a predictive hypoglycaemia alert function on hypoglycaemia in physical activity for people with type 1 diabetes (PACE)
Rilstone SK, Oliver N, Godsland IF, et al.
Diabetes Technol Ther. Pub. online 9 Nov 2023.
Leggi
HOMA-IR and the Matsuda Index as predictors of progression to type 1 diabetes in autoantibody-positive relatives
Petrelli A, Cugnata F, Carnovale D, et al.
Diabetologia. Pub. online 2 Nov 2023.
Leggi
Role of glycosuria in SGLT2 inhibitor-induced cardio-renal protection: a mechanistic analysis of the CREDENCE trial
Ferrannini E, Solini A, Baldi S, et al.
Diabetes. 2023;db230448.
Leggi
Effects of GLP1RAs on pregnancy rate and menstrual cyclicity in women with polycystic ovary syndrome: a meta-analysis and systematic review
Zhou L, Qu H, Yang L, Shou L
BMC Endocr Disord. 2023;23(1):245.
Leggi
Impact of a dual glucose‐dependent insulinotropic peptide/glucagon‐like peptide‐1 receptor agonist tirzepatide on heart rate among patients with type 2 diabetes: A systematic review and pairwise and network meta‐analysis
Yang Y, He L, Liu P, et al.
Diabetes Obes Metab. Pub. Online 20 Oct 2023.
Leggi
Randomized trial of the insulin-only iLet bionic pancreas for the treatment of cystic fibrosis–related diabetes
Sherwood JS, Castellanos LE, O’Connor MY, et al.
Diabetes Care. 2023 Oct 24:dc231411.
Leggi